company background image
BIM logo

bioMérieux ENXTPA:BIM Stock Report

Last Price

€101.20

Market Cap

€12.0b

7D

2.7%

1Y

2.7%

Updated

27 Mar, 2024

Data

Company Financials +

BIM Stock Overview

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

BIM fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for BIM from our risk checks.

bioMérieux S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for bioMérieux
Historical stock prices
Current Share Price€101.20
52 Week High€106.00
52 Week Low€84.54
Beta0.14
1 Month Change-1.99%
3 Month Change1.26%
1 Year Change2.70%
3 Year Change-6.73%
5 Year Change30.58%
Change since IPO912.00%

Recent News & Updates

bioMérieux S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Mar 17
bioMérieux S.A. Just Missed Earnings - But Analysts Have Updated Their Models

These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

Mar 15
These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings

Jan 27
bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings

Recent updates

bioMérieux S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Mar 17
bioMérieux S.A. Just Missed Earnings - But Analysts Have Updated Their Models

These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

Mar 15
These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings

Jan 27
bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings

bioMérieux (EPA:BIM) Has More To Do To Multiply In Value Going Forward

Jan 06
bioMérieux (EPA:BIM) Has More To Do To Multiply In Value Going Forward

A Look At The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

Dec 16
A Look At The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

Oct 23
These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

bioMérieux (EPA:BIM) Has Some Way To Go To Become A Multi-Bagger

Oct 05
bioMérieux (EPA:BIM) Has Some Way To Go To Become A Multi-Bagger

There May Be Reason For Hope In bioMérieux's (EPA:BIM) Disappointing Earnings

Sep 15
There May Be Reason For Hope In bioMérieux's (EPA:BIM) Disappointing Earnings

Estimating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

Sep 07
Estimating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?

Jun 30
Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?

Returns At bioMérieux (EPA:BIM) Appear To Be Weighed Down

Jun 09
Returns At bioMérieux (EPA:BIM) Appear To Be Weighed Down

Is bioMérieux (EPA:BIM) Using Too Much Debt?

Mar 31
Is bioMérieux (EPA:BIM) Using Too Much Debt?

The Return Trends At bioMérieux (EPA:BIM) Look Promising

Feb 23
The Return Trends At bioMérieux (EPA:BIM) Look Promising

Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?

Jan 27
Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?

bioMérieux (EPA:BIM) Has A Pretty Healthy Balance Sheet

Dec 16
bioMérieux (EPA:BIM) Has A Pretty Healthy Balance Sheet

bioMérieux (EPA:BIM) Ticks All The Boxes When It Comes To Earnings Growth

Oct 18
bioMérieux (EPA:BIM) Ticks All The Boxes When It Comes To Earnings Growth

Is bioMérieux (EPA:BIM) Using Too Much Debt?

Sep 14
Is bioMérieux (EPA:BIM) Using Too Much Debt?

Investors Should Be Encouraged By bioMérieux's (EPA:BIM) Returns On Capital

Aug 11
Investors Should Be Encouraged By bioMérieux's (EPA:BIM) Returns On Capital

An Intrinsic Calculation For bioMérieux S.A. (EPA:BIM) Suggests It's 20% Undervalued

Jul 23
An Intrinsic Calculation For bioMérieux S.A. (EPA:BIM) Suggests It's 20% Undervalued

Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?

Jul 05
Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?

bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85

May 26
bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85

Shareholders Would Enjoy A Repeat Of bioMérieux's (EPA:BIM) Recent Growth In Returns

May 11
Shareholders Would Enjoy A Repeat Of bioMérieux's (EPA:BIM) Recent Growth In Returns

bioMérieux (EPA:BIM) Is Paying Out A Larger Dividend Than Last Year

Apr 23
bioMérieux (EPA:BIM) Is Paying Out A Larger Dividend Than Last Year

bioMérieux (EPA:BIM) Has Announced That It Will Be Increasing Its Dividend To €0.85

Apr 09
bioMérieux (EPA:BIM) Has Announced That It Will Be Increasing Its Dividend To €0.85

bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85

Mar 25
bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85

Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?

Mar 13
Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?

I Ran A Stock Scan For Earnings Growth And bioMérieux (EPA:BIM) Passed With Ease

Feb 08
I Ran A Stock Scan For Earnings Growth And bioMérieux (EPA:BIM) Passed With Ease

Why We Like The Returns At bioMérieux (EPA:BIM)

Dec 21
Why We Like The Returns At bioMérieux (EPA:BIM)

Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

Dec 07
Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

Here's Why We Think bioMérieux (EPA:BIM) Is Well Worth Watching

Nov 07
Here's Why We Think bioMérieux (EPA:BIM) Is Well Worth Watching

Is bioMérieux (EPA:BIM) A Risky Investment?

Oct 07
Is bioMérieux (EPA:BIM) A Risky Investment?

Investors Shouldn't Overlook bioMérieux's (EPA:BIM) Impressive Returns On Capital

Sep 22
Investors Shouldn't Overlook bioMérieux's (EPA:BIM) Impressive Returns On Capital

Estimating The Fair Value Of bioMérieux S.A. (EPA:BIM)

Sep 07
Estimating The Fair Value Of bioMérieux S.A. (EPA:BIM)

Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today

Aug 06
Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today

There's Been No Shortage Of Growth Recently For bioMérieux's (EPA:BIM) Returns On Capital

Jun 15
There's Been No Shortage Of Growth Recently For bioMérieux's (EPA:BIM) Returns On Capital

A Look At The Fair Value Of bioMérieux S.A. (EPA:BIM)

May 31
A Look At The Fair Value Of bioMérieux S.A. (EPA:BIM)

Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today

Apr 30
Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today

bioMérieux (EPA:BIM) Could Easily Take On More Debt

Mar 28
bioMérieux (EPA:BIM) Could Easily Take On More Debt

The Trend Of High Returns At bioMérieux (EPA:BIM) Has Us Very Interested

Mar 13
The Trend Of High Returns At bioMérieux (EPA:BIM) Has Us Very Interested

Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

Feb 25
Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)

If You Had Bought bioMérieux (EPA:BIM) Shares Five Years Ago You'd Have Earned 237% Returns

Feb 09
If You Had Bought bioMérieux (EPA:BIM) Shares Five Years Ago You'd Have Earned 237% Returns

If You Like EPS Growth Then Check Out bioMérieux (EPA:BIM) Before It's Too Late

Jan 20
If You Like EPS Growth Then Check Out bioMérieux (EPA:BIM) Before It's Too Late

Could The Market Be Wrong About bioMérieux S.A. (EPA:BIM) Given Its Attractive Financial Prospects?

Dec 30
Could The Market Be Wrong About bioMérieux S.A. (EPA:BIM) Given Its Attractive Financial Prospects?

These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

Dec 17
These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well

Has bioMérieux (EPA:BIM) Got What It Takes To Become A Multi-Bagger?

Dec 03
Has bioMérieux (EPA:BIM) Got What It Takes To Become A Multi-Bagger?

Shareholder Returns

BIMFR Medical EquipmentFR Market
7D2.7%0.6%0.4%
1Y2.7%27.4%9.6%

Return vs Industry: BIM underperformed the French Medical Equipment industry which returned 27.7% over the past year.

Return vs Market: BIM underperformed the French Market which returned 10.6% over the past year.

Price Volatility

Is BIM's price volatile compared to industry and market?
BIM volatility
BIM Average Weekly Movement2.9%
Medical Equipment Industry Average Movement5.3%
Market Average Movement4.2%
10% most volatile stocks in FR Market9.8%
10% least volatile stocks in FR Market2.2%

Stable Share Price: BIM has not had significant price volatility in the past 3 months.

Volatility Over Time: BIM's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
196312,846Pierre Bouludhttps://www.biomerieux.com

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests.

bioMérieux S.A. Fundamentals Summary

How do bioMérieux's earnings and revenue compare to its market cap?
BIM fundamental statistics
Market cap€11.95b
Earnings (TTM)€357.60m
Revenue (TTM)€3.67b

33.4x

P/E Ratio

3.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIM income statement (TTM)
Revenue€3.67b
Cost of Revenue€1.62b
Gross Profit€2.06b
Other Expenses€1.70b
Earnings€357.60m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Sep 04, 2024

Earnings per share (EPS)3.03
Gross Margin55.99%
Net Profit Margin9.73%
Debt/Equity Ratio13.8%

How did BIM perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

28%

Payout Ratio

Does BIM pay a reliable dividends?

See BIM dividend history and benchmarks
When do you need to buy BIM by to receive an upcoming dividend?
bioMérieux dividend dates
Ex Dividend DateJun 07 2024
Dividend Pay DateJun 11 2024
Days until Ex dividend71 days
Days until Dividend pay date75 days

Does BIM pay a reliable dividends?

See BIM dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.